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The aim of this study was to assess the relationships of fatness and ﬁtness with metabolic risk factors, including liver transaminases
and inﬂammation in obese youth, taking in account gender, age, and pubertal stage. 241 children were studied (135 girls), age
11.9±2.2 years (x ±SD), Body Mass Index z score 5.4±2.7. For girls, VO2max was signiﬁcantly associated with insulin (P = .001),
Insulin resistance (HOMA-IR) (P = .005), and ALT (P = .012); a relationship was displayed between ﬁbrinogen and age and
% fat mass (FM) (P = .008); for boys, relationships were found between VO2max and diastolic blood pressure and triglycerides;
independentassociationswerealsofoundbetweenageandinsulin,HOMA-IRandHDLcholesterol;ﬁbrinogenandsedimentation
rate were related (P ≤ .004)with%FM.Theirrelationshipsareobservedfromyoungageandincreasewiththecontinuousincrease
of factors. This supports the need to treat overweight as soon as it is detected; improving CRF is one of the ways which could be
used to prevent the complications of obesity.
1.Introduction
Overweight is associated with an increased cardiovascular
risk, even in youth [1, 2]. It is also associated with a
decreased cardiorespiratory ﬁtness (CRF), which is liable to
contribute to obesity itself. Several large reports clearly show
a relationship between decreased CRF and the occurrence
of metabolic risk factors in overweight adults and youth.
Whether ﬁtness and fatness have independent inﬂuences on
metabolic risk, however, is not fully explained [3, 4].
Some of the studies addressed only one individual factor
[5–9] but most of them clustered these risks in “metabolic
syndrome” (MS) [8, 10–13]; MS usually associates with obe-
sity, dyslipoproteinemia (raised triglyceride and/or reduced
HDL-cholesterol levels), hypertension, and insulin resistance
or diabetes, but variables included in the MS and their
relative weight vary among deﬁnitions; the last of them
was given by the International Diabetes Federation [14].
Nonalcoholic fatty liver disease is frequently associated with
MS, so that it has been proposed as a core feature of it
[15, 16]. In addition inﬂammation is never included in
the criteria of MS, while it seems to be involved in the
development of its consequences [1, 17].
The value of MS concept itself is still debated [18]. A
recent WHO Expert Consultation came to the conclusions
that it is not a useful diagnostic or management tool [19].
The present study assessed the respective relationships
of CRF and fatness on individual components of MS,
including liver transaminases as a surrogate of nonalcoholic
fatty liver disease [15, 16]; ﬁbrinogen and sedimentation
rate were added as markers of inﬂammation; CRF was
measured by determining the maximal oxygen consump-
tion (VO2max); the marker of overweight was fat mass,
instead of BMI, because this latter one is a less valid
measurement of body fatness in children and does not
discriminate between muscle and fat [20] and it has been2 International Journal of Pediatrics
shown to be less discriminant than fatness as suggested
by a recent report [21]; we took into account the gender
and the pubertal development of adolescents, owing to
the changes that occur in their lifestyle and hormonal
status.
2.SubjectsandMethods
The study is part of a research protocol on the genetics
of child obesity, which has been approved by the Ethics
Committee of the Hˆ otel Dieu Hospital (Paris); a written
consenttotheinclusioninthestudywasgivenbyeachchild’s
parents and by adolescents themselves [22].
Subjects were children and adolescents attending the
specialized clinic of University Hospital of Caen; they were
routinely screened before treatment.
The clinical examination of children was performed by
the same clinician. They were all apparently healthy with
no obvious endocrine disease. Pubertal stage was assessed
according to Tanner criteria [23]. Weight was assessed with
an electronic beam balance; height was measured twice by
the same examiner to the nearest 0.5cm. Body mass index
(BMI) was calculated (kg/m2). Patients were considered as
overweight when their BMI was over 2SD of the available
French charts [24], which ﬁt better with the local population
than the IOTF charts; data were also compared with IOTF
cut oﬀ points [25]. Blood pressure (BP) was measured by
an automatic device on a sitting patient, at least twice,
at the end of a consultation (Agilent A1; Agilent 91745
Massy France).
Blood sample was drawn after an overnight fast, for mea-
surements of plasma glucose, insulin, triglycerides, HDL and
LDL cholesterol, alanine aminotransferase (ALT), aspartate
aminotransferase (AST), sedimentation rate and ﬁbrinogen.
Homeostasis model assessment-insulin resistance (HOMA-
IR) was calculated as a measure of insulin resistance (insulin
(mU/L) ∗ plasma glucose (mmol/L)/22.5).
Body composition (total and relative (%) fat and fat-
free mass) was measured by X-ray absorptiometry (DEXA)
(HOLOGIC QDR-4500 A) [26].
VO2Max was measured by a previously validated proto-
col reported [26]; it was adapted from Achten [27]; the use
of this graded exercise to exhaustion gives an exact value of
the peak VO2 [26, 27]; subjects performed a graded exercise
on a bicycle ergometer (ERGOLINE 500, Bosch) linked to
a gas analyzer (Ergocard SCHILLER). Before the test, the
children were given several minutes to familiarise themselves
with the ergometer and to adapt to the valve/mouthpiece.
The subjects warmed up for 5 minutes at 0W. The ﬁrst step
was ﬁxed at 30W with a rectangular progression of 20W
every 3 minutes 30 seconds, until exhaustion.
2.1. Statistical Analysis. Results were expressed as mean ±
1SD; statistical analysis used univariate regression analysis
between VO2max and anthropometric and biologic data;
multivariate analyses performed on each gender; they used
age and % fat mass as covariates of VO2max. Tanner stage was
also tested as covariate.
The level of signiﬁcance was set at P<. 05.




Age Years 11.9 2.3 12.1 2.3
Tanner 3.0 1.8 2.0 1.3
Weight k 62.4 16.8 69.0 21.2
Height m 1.52 0.11 1.55 0.12
BMI k/m2 26.7 4.5 28.1 5.8
z Score BMI 5.1 2.5 5.8 2.9
Overweight (IOTF
cut oﬀ points) %4 7 3 7
Obesity (IOTF cut
oﬀ points) %5 3 6 3
Fat Free Mass % 56.6 6.4 57.6 6.8
Fat Mass % 40.6 6.4 39.3 6.6
VO2max mLO2/k/min 25.5 5.1 27.9 6.1
Systolic BP MmHg 116 19 120 13
D i a s t o l i c B P M m H g 6 11 26 510
Fasting Glucose mmol/L 4.7 0.4 4.9 0.4
Fasting Insulin mU/L 10.4 5.4 10.9 7.2
HOMA-IR 2.1 1.1 2.4 1.7
HDL Cholesterol Mmol/L 1.5 0.4 1.4 0.3
LDL Cholesterol mmol/L 2.8 0.9 2.7 1.3
Triglycerides mmol/L 0.8 0.4 0.9 0.5
A S T I U / L 2 382 47
A L T I U / L 2 472 8 17
Sedimentation rate 13 6 12 7
Fibrinogen g/L 3.6 0.8 3.6 0.7
3. Results
241 children were studied (135 girls), aged 11.9 ± 2.2y e a r s
(x ± SD), range: 6.2 ±17.9; their BMI z score was 5.4 ± 2.7.
Descriptive data are given in Table 1.
Univariate regressions (Table 2) displayed signiﬁcant
relationships between VO2max and age, pubertal develop-
ment, BMI, body composition parameters, insulin and
HOMA-IR, lipids and ALT (≤0.02), and inﬂammation
parameters (P ≤ .0005).
Table 3 shows the results of multivariate regression
analysis. Since Tanner stage did not enter in any model,
it was discarded from analysis. For girls, VO2max remained
signiﬁcantly associated with insulin (P = .001), HOMA-
IR (P = .005), and ALT (P = .012); a relationship was
displayed between ﬁbrinogen and age and % fat mass (P =
.008); for boys, relationships were found between VO2max
and diastolic BP and triglycerides; independent associations
were also found between age and insulin, HOMA-IR, and
HDL cholesterol; ﬁbrinogen and sedimentation rate were
related (P ≤ .004) with %FM.International Journal of Pediatrics 3
Table 2: Univariate regression analysis between VO2max and
metabolic risk factors.
P FT
Age .0062 7,64 −2.976
Tanner stage .0018 10.043 −3.169
BMI <.0001 83.809 −9.55
z score <.0001 48.949 −6.99
Fat Free Mass kg .0002 14.576 −3.818
Fat Free Mass % <.0001 43.856 6.622
Fat Mass kg <.0001 92.285 −9.761




Fasting Insulin <.0001 −5.52
HOMA-IR <.0001 −4.98
Triglycerides .010 −2.59




Sedimentation rate .0002 14.26 −3.776
Fibrinogen .0005 8.012 −2.831
4. Discussion
CRF and adiposity are associated with metabolic risk factors
and cardiac and vascular risks; it is known that these risks are
alreadypresentinyouth[2,28].Themainrolesareattributed
e i t h e rt oﬁ t n e s so rf a t n e s s[ 3, 8]. In fact an inﬂuence of
both variables could be expected owing to the relationships
between obesity and movement eﬃciency [29] which lately
led to social exclusion, but diﬀerences in statistical analysis,
ways of assessing metabolic risk, adiposity, and/or taking
account of gender and sexual development could explain at
least part of these discrepancies.
The potential metabolic interdependence between these
risks lead to the concept of metabolic syndrome. Currently
this concept is debated [18, 19], and these risk factors could
have only statistical relations. So studying the individual
relationships between each of them and with ﬁtness or
adiposity could be of interest to understand the mechanisms
involved in the health risks of obesity; it could also give
more speciﬁc aims to improve the eﬃciency of prevention
campaigns [30].
The present study showed mainly a relation between
CRF (VO2max) and insulin metabolism in girls; VO2max
was signiﬁcantly related to diastolic BP in boys and to
ALT in girls. Age was mainly involved in the relationships
with insulin and lipids in boys and with inﬂammation in
girls. Apart from the relationship between inﬂammation
parameters in boys, the degree of adiposity did not appear
to play a main inﬂuence on the early occurrence of risk
factors. None of these relationships depended on pubertal
development.
It seemed useful to address current adiposity and not
only BMI which is the sum of fat free and fat mass [20];
a previous study shows that measured fat mass is a better
variable to assess the metabolic risk of obesity, owing to
the endocrine and inﬂammatory actions of adipose tissue
[1, 21]; most of the studies use BMI as marker of adiposity
[13]; their conclusions could be taken with caution since an
increased BMI can be associated with an increased muscle
mass, speciﬁcally in active boys.
Subjects of the present study did not fulﬁl the criteria
of metabolic syndrome, whatever the deﬁnition used; it
is known that the risk of developing MS factors increases
with the degree of overweight [1, 10, 18]. In some reports,
the relationships between MS and CRF only occur at high
degrees of adiposity [9]. Our regression analysis showed a
direct eﬀect of age on inﬂammation and lipoproteins, from
young age and from a moderate degree of excess adiposity;
theseobservations,addedtotheearlydevelopmentofarterial
dysfunction [28] and the relationship between child obesity
and its complications in adult [31], support a precocious
treatment of overweight in youth.
When it is assessed, no eﬀect of pubertal status is
observed [9].
Diﬀerences were found between boys and girls in the
relationships between risk factors (lipid proﬁle, insulin
resistance) and ﬁtness by some authors [7, 32, 33] and not
by others [9]; such diﬀerences were expected, due to the
diﬀerence in insulin sensitivity between both sexes [34].
They should not result from sex hormones, since no eﬀect
of pubertal stage was found; more diﬀerences are found in
lifestyle; boys are more active than girls, and physical activity
aﬀects all cardiovascular risks [7, 17].
Imperatore ﬁnds a signiﬁcant association between
insulin sensitivity and CRF only in boys [7]; however, since
only BMI was measured, this association could have resulted
from a higher muscle mass in boys rather than from an
increased adiposity; the relationship between fasting glucose
and CRF disappears when body fat is taken into account; in
the same report, HOMA and fasting glucose are negatively
associated with CRF only in the higher body fat tertile [9];
Gutin ﬁnds also a relationship between VO2max and the
percentage of body fat mass [21, 32] while others ﬁnd no
relationship between VO2max and insulin sensitivity [11].
CRF could interact with metabolic risk factors through
insulin resistance. Insulin resistance is reported as the key
mechanism in the development of metabolic complications
of obesity [1], yet these models usually do not take physical
activity or CRF into account. Physical training enhances
insulin sensitivity in the exercised muscle and enhances
muscle contraction-induced glucose uptake in the muscle;
the mechanisms include postreceptor insulin signalling,
increased glycogen synthesis, and enhanced muscle capillar-
ization and blood ﬂow [35].
Obesity is a low-grade inﬂammation disease, positively
associated with body fat and negatively with CRF [9]; this
inﬂammation, yet not included in MS criteria, is a possible
pathway in its pathogenesis: it induces insulin resistance
and MS; insulin resistance promotes inﬂammation further
through an increase in free fatty acids [17].4 International Journal of Pediatrics
Table 3: Multivariate regression between metabolic risk factors and VO2Max, using age and % fat mass as covariates.
Girls Boys
F P F P
Systolic BP 1.938 .129 2.508 .066
Diastolic BP 0.201 .896 3.294 .025 VO2Max: 0.048
Fasting Glucose 1.476 .226 1.968 .125
Fasting Insulin 5.683 .001 VO2Max: 0.002 6.317 <.0001 Age: 0.017
HOMA-IR 4.530 .005 VO2Max: 0.001 6.275 <.0001 Age: 0.026
Triglycerides 2.384 .073 3.976 .010 VO2Max: 0.034
HDL Cholesterol 1.055 .371 3.139 .029 Age: 0.039
LDL Cholesterol 0.846 .472 0.930 .431
AST 1.051 .373 0.514 .674
ALT 3.829 .012 VO2Max: 0.073 2.492 .065
Fibrinogen 4.21 .008 Age: 0.040 % FM: 0.007 2.938 .038 %FM: 0.018
Sedimentation rate 4.077 .009 4.085 <.001 %FM: 0.045
Tanner stage did not signiﬁcantly enter in any model tested.
The increase in liver transaminases is associated to other
components of MS, particularly to insulin resistance [15, 16,
33, 36]; the precise relationship between fatty liver and MS
is not precisely known but is likely to also involve insulin
resistance [37, 38]; in addition, the present study shows that
it is under regulation of CRF, such as other risk factors [38].
So far, no speciﬁc treatment of nonalcoholic fatty disease
hasbeenproposed[39];itisknownthatweightlossimproves
liver dysfunction [32, 33]; the present observation suggests
that lifestyle interventions aimed at enhancing CRF should
also be eﬃcient in improving liver parameters.
5. Conclusions
CRF is one of the parameters associated with individual
metabolic risk factors in young overweight subjects, together
with age and percentage of fat mass. As expected, the
main relationship was found with insulin resistance. CRF
was also associated with other variables often associated
with metabolic risk of obesity, that is, transaminases and
inﬂammation.
The relationships diﬀered between boys and girls and
were not inﬂuenced by their pubertal stage. They were
observed from young age and increased continuously with
the factors studied.
T h i ss u p p o rt st h en e e dt ot r e a to v e r w e i g h ta ss o o na si ti s
detected; improving CRF is one of the ways which could be
used to prevent the complications of obesity.
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